Ernexa Therapeutics Inc. Selling, General and Administrative Expense
Ernexa Therapeutics Inc. (ERNA) reported Selling, General and Administrative Expense of $8.09 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2021-03-11
- Ernexa Therapeutics Inc. selling, general and administrative expense for the quarter ending 2020-12-31 was $1.35M, a 53.06% decline year-over-year.
- Ernexa Therapeutics Inc. selling, general and administrative expense for the quarter ending 2020-09-30 was $2.07M, a 39.41% decline year-over-year.
- Ernexa Therapeutics Inc. selling, general and administrative expense for the quarter ending 2020-06-30 was $1.59M, a 53.39% decline year-over-year.
- Ernexa Therapeutics Inc. selling, general and administrative expense for the quarter ending 2020-03-31 was $3.08M, a 11.19% decline year-over-year.
- Ernexa Therapeutics Inc. selling, general and administrative expense for fiscal 2020 was $8.09M, a 38.59% decline from fiscal 2019.
- Ernexa Therapeutics Inc. selling, general and administrative expense for fiscal 2019 was $13.18M, a 8.91% decline from fiscal 2018.
- Ernexa Therapeutics Inc. selling, general and administrative expense for fiscal 2018 was $14.46M, a 7.21% decline from fiscal 2017.
- Ernexa Therapeutics Inc. selling, general and administrative expense for fiscal 2017 was $15.59M, a 5.29% decline from fiscal 2016.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 3 month as first filed | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 6 month as first filed | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 9 month as first filed | Selling, General and Administrative Expense 12 month | Selling, General and Administrative Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | $1.35M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $3.42M derived: sum of 2 quarters · filed 2021-03-11 | $5.01M derived: sum of 3 quarters · filed 2021-03-11 | $8.09M 10-K · filed 2021-03-11 | ||||
| 2020-09-30 | $2.07M 10-Q · filed 2020-11-13 | $3.66M derived: sum of 2 quarters · filed 2020-11-13 | $6.74M 10-Q · filed 2020-11-13 | $9.62M derived: sum of 4 quarters · filed 2021-03-11 | ||||
| 2020-06-30 | $1.59M 10-Q · filed 2020-08-07 | $4.67M 10-Q · filed 2020-08-07 | $7.55M derived: sum of 3 quarters · filed 2021-03-11 | $10.96M derived: sum of 4 quarters · filed 2021-03-11 | ||||
| 2020-03-31 | $3.08M 10-Q · filed 2020-05-20 | $5.95M derived: sum of 2 quarters · filed 2021-03-11 | $9.37M derived: sum of 3 quarters · filed 2021-03-11 | $12.79M derived: sum of 4 quarters · filed 2021-03-11 | ||||
| 2019-12-31 | $2.87M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $6.29M derived: sum of 2 quarters · filed 2021-03-11 | $9.71M derived: sum of 3 quarters · filed 2021-03-11 | $13.18M 10-K · filed 2021-03-11 | ||||
| 2019-09-30 | $3.41M 10-Q · filed 2020-11-13 | $3.46M 10-Q · filed 2019-11-01 | $6.83M derived: sum of 2 quarters · filed 2020-11-13 | $10.30M 10-Q · filed 2020-11-13 | $10.36M 10-Q · filed 2019-11-01 | $13.64M derived: sum of 4 quarters · filed 2020-11-13 | ||
| 2019-06-30 | $3.42M 10-Q · filed 2020-08-07 | $6.89M 10-Q · filed 2020-08-07 | $6.89M 10-Q · filed 2019-08-12 | $10.23M derived: sum of 3 quarters · filed 2020-08-07 | $13.67M derived: sum of 4 quarters · filed 2020-08-07 | |||
| 2019-03-31 | $3.47M 10-Q · filed 2020-05-20 | $3.47M 10-Q · filed 2019-05-14 | $6.81M derived: sum of 2 quarters · filed 2020-05-20 | $10.25M derived: sum of 3 quarters · filed 2020-05-20 | $13.91M derived: sum of 4 quarters · filed 2020-05-20 | |||
| 2018-12-31 | $3.34M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | $6.78M derived: sum of 2 quarters · filed 2020-03-19 | $10.44M derived: sum of 3 quarters · filed 2020-03-19 | $14.46M 10-K · filed 2020-03-19 | $14.49M 10-K · filed 2019-03-22 | |||
| 2018-09-30 | $3.44M 10-Q · filed 2019-11-01 | $7.10M derived: sum of 2 quarters · filed 2019-11-01 | $11.12M 10-Q · filed 2019-11-01 | $15.08M derived: sum of 4 quarters · filed 2019-11-01 | ||||
| 2018-06-30 | $3.66M 10-Q · filed 2019-08-12 | $7.68M 10-Q · filed 2019-08-12 | $11.64M derived: sum of 3 quarters · filed 2019-08-12 | $15.27M derived: sum of 4 quarters · filed 2019-08-12 | ||||
| 2018-03-31 | $4.02M 10-Q · filed 2019-05-14 | $7.98M derived: sum of 2 quarters · filed 2019-05-14 | $11.62M derived: sum of 3 quarters · filed 2019-05-14 | $15.47M derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | $3.96M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $7.59M derived: sum of 2 quarters · filed 2019-03-22 | $11.45M derived: sum of 3 quarters · filed 2019-03-22 | $15.59M 10-K · filed 2019-03-22 | ||||
| 2017-09-30 | $3.64M 10-Q · filed 2018-11-09 | $7.49M derived: sum of 2 quarters · filed 2018-11-09 | $11.63M 10-Q · filed 2018-11-09 | $15.73M derived: sum of 4 quarters · filed 2018-11-09 | ||||
| 2017-06-30 | $3.86M 10-Q · filed 2018-08-06 | $7.99M 10-Q · filed 2018-08-06 | $12.09M derived: sum of 3 quarters · filed 2018-08-06 | $16.10M derived: sum of 4 quarters · filed 2018-08-06 | ||||
| 2017-03-31 | $4.13M 10-Q · filed 2018-05-11 | $8.23M derived: sum of 2 quarters · filed 2018-05-11 | $12.24M derived: sum of 3 quarters · filed 2018-05-11 | $16.39M derived: sum of 4 quarters · filed 2018-05-11 | ||||
| 2016-12-31 | $4.10M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $8.11M derived: sum of 2 quarters · filed 2018-03-09 | $12.26M derived: sum of 3 quarters · filed 2018-03-09 | $16.46M 10-K · filed 2018-03-09 | ||||
| 2016-09-30 | $4.01M 10-Q · filed 2017-11-08 | $8.16M derived: sum of 2 quarters · filed 2017-11-08 | $12.36M 10-Q · filed 2017-11-08 | $16.31M derived: sum of 4 quarters · filed 2017-11-08 | ||||
| 2016-06-30 | $4.15M 10-Q · filed 2017-08-04 | $8.35M 10-Q · filed 2017-08-04 | $12.31M derived: sum of 3 quarters · filed 2017-08-04 | $16.38M derived: sum of 4 quarters · filed 2017-08-04 | ||||
| 2016-03-31 | $4.20M 10-Q · filed 2017-05-04 | $8.15M derived: sum of 2 quarters · filed 2017-05-04 | $12.23M derived: sum of 3 quarters · filed 2017-05-04 | $17.10M derived: sum of 4 quarters · filed 2017-05-04 | ||||
| 2015-12-31 | $3.95M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | $8.03M derived: sum of 2 quarters · filed 2017-03-09 | $12.90M derived: sum of 3 quarters · filed 2017-03-09 | $18.06M 10-K · filed 2017-03-09 | ||||
| 2015-09-30 | $4.08M 10-Q · filed 2016-11-09 | $8.94M derived: sum of 2 quarters · filed 2016-11-09 | $14.11M 10-Q · filed 2016-11-09 | $18.66M derived: sum of 4 quarters · filed 2016-11-09 | ||||
| 2015-06-30 | $4.87M 10-Q · filed 2016-08-04 | $10.03M 10-Q · filed 2016-08-04 | $14.59M derived: sum of 3 quarters · filed 2016-08-04 | $19.45M derived: sum of 4 quarters · filed 2016-08-04 | ||||
| 2015-03-31 | $5.16M 10-Q · filed 2016-05-09 | $9.72M derived: sum of 2 quarters · filed 2016-05-09 | $14.58M derived: sum of 3 quarters · filed 2016-05-09 | $19.16M derived: sum of 4 quarters · filed 2016-05-09 | ||||
| 2014-12-31 | $4.56M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $9.42M derived: sum of 2 quarters · filed 2016-03-15 | $14.00M derived: sum of 3 quarters · filed 2016-03-15 | $18.37M 10-K · filed 2016-03-15 | ||||
| 2014-09-30 | $4.86M 10-Q · filed 2015-11-09 | $9.44M derived: sum of 2 quarters · filed 2015-11-09 | $13.81M 10-Q · filed 2015-11-09 | $17.85M derived: sum of 4 quarters · filed 2015-11-09 | ||||
| 2014-06-30 | $4.58M 10-Q · filed 2015-08-10 | $8.95M 10-Q · filed 2015-08-10 | $12.98M derived: sum of 3 quarters · filed 2015-08-10 | $17.01M derived: sum of 4 quarters · filed 2015-08-10 | ||||
| 2014-03-31 | $4.39M 10-Q · filed 2015-05-08 | $8.41M derived: sum of 2 quarters · filed 2015-05-08 | $12.44M derived: sum of 3 quarters · filed 2015-05-08 | $16.39M derived: sum of 4 quarters · filed 2015-05-08 | ||||
| 2013-12-31 | $4.02M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-27 | $8.05M derived: sum of 2 quarters · filed 2015-03-27 | $12.00M derived: sum of 3 quarters · filed 2015-03-27 | $16.22M 10-K · filed 2015-03-27 | $16.45M 10-K · filed 2014-03-31 | |||
| 2013-09-30 | $4.03M 10-Q · filed 2014-11-07 | $4.05M 10-Q · filed 2013-11-14 | $7.99M derived: sum of 2 quarters · filed 2014-11-07 | $12.20M 10-Q · filed 2014-11-07 | $12.32M 10-Q · filed 2013-11-14 | $16.07M derived: sum of 4 quarters · filed 2014-11-07 | ||
| 2013-06-30 | $3.96M 10-Q · filed 2014-08-14 | $3.98M 10-Q · filed 2013-08-14 | $8.17M 10-Q · filed 2014-08-14 | $8.27M 10-Q · filed 2013-08-14 | $12.04M derived: sum of 3 quarters · filed 2014-08-14 | $16.30M derived: sum of 4 quarters · filed 2014-08-14 | ||
| 2013-03-31 | $4.28M 10-Q · filed 2014-05-15 | $8.09M derived: sum of 2 quarters · filed 2014-05-15 | $12.35M derived: sum of 3 quarters · filed 2014-05-15 | $17.26M derived: sum of 4 quarters · filed 2014-05-15 | ||||
| 2012-12-31 | $3.81M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $8.06M derived: sum of 2 quarters · filed 2014-03-31 | $12.98M derived: sum of 3 quarters · filed 2014-03-31 | $18.25M 10-K · filed 2014-03-31 | ||||
| 2012-09-30 | $4.26M 10-Q · filed 2013-11-14 | $9.17M derived: sum of 2 quarters · filed 2013-11-14 | $14.44M 10-Q · filed 2013-11-14 | $19.50M derived: sum of 4 quarters · filed 2013-11-14 | ||||
| 2012-06-30 | $4.91M 10-Q · filed 2013-08-14 | $10.19M 10-Q · filed 2013-08-14 | $15.25M derived: sum of 3 quarters · filed 2013-08-14 | $20.43M derived: sum of 4 quarters · filed 2013-08-14 | ||||
| 2012-03-31 | $5.27M 10-Q · filed 2013-05-13 | $10.33M derived: sum of 2 quarters · filed 2013-05-13 | $15.51M derived: sum of 3 quarters · filed 2013-05-13 | $20.89M derived: sum of 4 quarters · filed 2013-05-13 | ||||
| 2011-12-31 | $5.06M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-29 | $10.24M derived: sum of 2 quarters · filed 2013-03-29 | $15.62M derived: sum of 3 quarters · filed 2013-03-29 | $20.45M 10-K · filed 2013-03-29 | ||||
| 2011-09-30 | $5.18M 10-Q · filed 2012-11-09 | $10.55M derived: sum of 2 quarters · filed 2012-11-09 | $15.39M 10-Q · filed 2012-11-09 | $19.81M derived: sum of 4 quarters · filed 2012-11-09 | ||||
| 2011-06-30 | $5.37M 10-Q · filed 2012-08-14 | $10.21M 10-Q · filed 2012-08-14 | $14.63M derived: sum of 3 quarters · filed 2012-08-14 | $19.30M derived: sum of 4 quarters · filed 2012-08-14 | ||||
| 2011-03-31 | $4.83M 10-Q · filed 2012-05-11 | $9.26M derived: sum of 2 quarters · filed 2012-05-11 | $13.92M derived: sum of 3 quarters · filed 2012-05-11 | $18.82M derived: sum of 4 quarters · filed 2012-05-11 | ||||
| 2010-12-31 | $4.42M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | $9.09M derived: sum of 2 quarters · filed 2012-03-30 | $13.99M derived: sum of 3 quarters · filed 2012-03-30 | $18.91M 10-K · filed 2012-03-30 | ||||
| 2010-09-30 | $4.67M 10-Q · filed 2011-11-14 | $9.56M derived: sum of 2 quarters · filed 2011-11-14 | $14.48M 10-Q · filed 2011-11-14 | |||||
| 2010-06-30 | $4.90M 10-Q · filed 2011-08-12 | $9.82M 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |